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Abstract
Exposure to ambient air particles matter (PM) has been associated with increased risk of lung cancer. Aberrant
tumor suppressor gene promoter methylation has emerged as a promising biomarker for cancers, including lung
cancer. Whether exposure to PM is associated with peripheral blood leukocyte (PBL) DNA methylation in tumor
suppressor genes has not been evaluated. In 63 male healthy steel workers with well-characterized exposure to
metal-rich particles nearby Brescia, Italy, we evaluated whether exposure to PM and metal components was
associated with PBL DNA methylation in 4 tumor suppressor genes (i.e., APC, p16, p53 and RASSF1A). Blood
samples were obtained on the 1st (baseline) and 4th day (post-exposure) of the same work week and DNA
methylation was measured using pyrosequencing. A linear mixed model was used to examine the correlations of
the exposure with promoter methylation levels. Mean promoter DNA methylation levels of APC or p16 were
significantly higher in post-exposure samples compared to that in baseline samples (p-values = 0.005 for APC, and
p-value = 0.006 for p16). By contrast, the mean levels of p53 or RASSF1A promoter methylation was decreased in
post-exposure samples compared to that in baseline samples (p-value = 0.015 for p53; and p-value < 0.001 for
RASSF1A). In post-exposure samples, APC methylation was positively associated with PM10 (b = 0.27, 95% CI:
0.13-0.40), and PM1 (b = 0.23, 95% CI: 0.09-0.38). In summary, ambient PM exposure was associated with PBL DNA
methylation levels of tumor suppressor genes of APC, p16, p53 and RASSF1A, suggesting that such methylation
alterations may reflect processes related to PM-induced lung carcinogenesis.
Introduction
Ambient and occupational exposure to particular matter
(PM) has been associated with increased risk of lung
cancer [1,2]. Although the carcinogenic potential of sev-
eral toxic metals in PM was well-recognized, the mole-
cular mechanisms underlying their association with
cancer risks remain poorly understood. Experimental
and epidemiologic studies suggest that PM mass and
metal components may induce critical carcinogenesis-
related biological changes, including oxidative stress,
immune deficiency, and chronic inflammation, which
have recently been shown to alter gene expression via
DNA methylation mechanism [3].
Growing evidence indicates that epigenetic dysregula-
tion of gene expression plays a primary role in cancer
etiology [4,5]. Methylation of 5’CpG islands in promoter
region has emerged as one of the most important epige-
netic mechanisms in the development of human cancers
[6]. Aberrant promoter methylation of a series of tumor
suppressor genes has been detected in blood leukocyte
DNA from lung cancer patients [7] and healthy subjects
exposed to carcinogens [8,9]. In our previous studies, we
have reported blood leukocyte global hypomethylation
in subjects exposed to PM and metal components
[10-12] and benzene [13]. Global hypomethylation is fre-
quently observed in cancer tissues, including lung can-
cer [14,15] and blood leukocytes of cancer patients [16]
and it often co-exists with gene-specific methylation
alterations [17]. However, whether ambient PM and its
metal components can induce DNA methylation altera-
tions in tumor suppressor genes, which may be involved
in air pollution-related lung carcinogenesis, has not
been examined.
DNA methylation is mitotically stable and can be pro-
pagated through cell division from mother to daughter
cells. However, experimental evidence from in vitro
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studies has shown that DNA methylation states in speci-
fic genes may change rapidly in response to environ-
mental stressors. Whether DNA methylation in tumor
suppressor genes changes in response to short-term
exposure to environmental chemicals is yet to be deter-
mined. Tumor suppressor gene hypermethylation is
widely proposed to represent one of the very early steps
in human carcinogenesis [17]. Even transient DNA
methylation changes may reflect condition of cellular
stress associated with altered apoptosis, cell cycle con-
trol, and cell proliferation that may lead to the accumu-
lation of persistent epigenetic and genetic damage after
repeated exposures or in the presence of other pro-car-
cinogenic insults [18].
Foundry work, a specific condition of exposure to
inhalable metal-rich particles, has been associated with
increased risk of lung cancer [19]. Even in modern foun-
dry facilities, workers are still exposed to substantially
higher levels of airborne PM compared to those found
outdoors [10]. In the present study of 63 foundry work-
ers with different levels of usual PM exposure, we exam-
ined the association of PM exposure with 4 tumor
suppressor genes (i.e., APC, p16, p53 and RASS1FA)
promoter DNA methylation levels. To capture the
potential effects of short PM exposures, we further eval-
uated the differences in DNA methylation measured at
the beginning and at the end of a work week.
Material and Methods
Study population
We recruited 63 male healthy workers free of cancer
and cardiovascular and pulmonary disease in an electric
steel plant in Brescia, Northern Italy, between April and
May 2006 as described previously [20]. All participants
had been working in the current job position for at least
one year. A self-administered questionnaire was used to
collect detailed information on lifestyle, drug use, recent
medical conditions, and residential history. Records
from the factory administrative and clinical files were
used to abstract information on occupational and past
medical history. In order to discriminate short- and
long-term effects of PM on biomarkers that are relevant
to diseases, we obtained blood samples at two different
times: i) the baseline sample was collected in the morn-
ing of the 1st day of a work week (following two days off
work) before the beginning of any work activity; ii) the
post-exposure sample was collected at the same time on
the 4th work day of the same week. Individual written
informed consent and approval from the local Institu-
tional Review Board were obtained before the study.
Exposure measurement
Measures of the airborne levels of PM mass and metal
components obtained in each of the 11 work areas of
the plant were used to estimate individual exposures as
described before [20]. During the three work days
between baseline and post-exposure samples collection,
each of the study subjects recorded the time that he
spent in each of the work areas. For each of the expo-
sures, we calculated the personal time-weighted average
exposure level by multiplying the time spent in each
area by the level of PM mass or metal components in
the area, which was then divided by the total time spent
at work. The exposure levels of each pollutant in each
of the work areas have shown very little variability over
time, as measures repeated over one year in a subset of
subjects showed very high correlation (r2 > 0.90).
Because all the study subjects reported in the question-
naire have performed their standard work routine dur-
ing the three days of the study, the time-weighted
personal levels of PM mass and metal components, in
addition to the exposure during the week of the study,
was also a measure of the usual exposure of the study
subjects [10].
Measures of PM mass included concentrations of air-
borne PM with aerodynamic diameters < 10 μm (PM10)
and < 1 μm (PM1) measured using a GRIMM 1100
light-scattering dust analyzer (Grimm Technologies, Inc.
Douglasville, GA, USA). We measured air concentra-
tions of individual metal particle components in PM10,
through multi-elemental analysis performed by means of
inductively coupled-plasma mass spectrometer (ICP-MS,
ELAN DRC II, Perkin Elmer, Waltham, MA, USA)
using the Total Quant method. External calibration was
performed using calibration standard 3, stock multi-ele-
ment (10 μg/ml; Perkin Elmer, Waltham, MA, USA).
The coefficient of variations for the metal concentra-
tions obtained in repeated measures varied between 4%
and 8%.
DNA Methylation measurement
We used EDTA tubes to collect 7 ml whole blood that
was promptly centrifuged on site at 2500 rpm for 15
minutes. The buffy coat (400 μl) was transferred in a
cryovial, immediately frozen in vapour phase of liquid
nitrogen, and shipped in nitrogen dry shippers to the
laboratory. DNA was extracted using the Wizard Geno-
mic DNA purification kit (Promega, Madison, WI, USA)
following the manufacturer’s instructions. The samples
collected on the 1st and 4th day were processed using
the same exact protocols. Promoter regions and ampli-
cons of four promoter CpG sites in APC, p53, or
RASSF1A and seven CpG sites in p16 are listed in Addi-
tional file 1, Table S1. For all assays, we used built-in
controls to verify bisulfite conversion efficiency. Com-
pared with other common methods of DNA methylation
analysis, pyrosequencing-based assays have the advan-
tage of producing individual measures of methylation at
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more than one CpG dinucleotide, thus reflecting more
accurately DNA methylation in the region.
Statistical Analysis
For each subject, the pyrosequencing-based analysis of
DNA methylation produced eight values each for APC,
p53 or RASS1FA (methylation at four CpG dinucleotide
sites for each of the genes, replicated in two analytical
measurements) and fourteen values for p16 (methylation
at seven CpG dinucleotide sites, replicated in two analy-
tical measurements). Each subject was tested twice for
baseline and post-exposure DNA sample. We first evalu-
ated differences between baseline and post-exposure
samples using the following model: Yijk = b0 + b1(Sam-
ple)k + b2(CpG position)j + ξijk + εijk, where b0 is the
overall intercept; b1 is the regression coefficient for the
difference between baseline and post-exposure sample;
b2 is the regression coefficient for the difference
between CpG dinucleotides position; i = 1,2,...,63 repre-
sents the subject; j = 1,2...4/7 represents the CpG dinu-
cleotides position; k = 1,2 represents the sample. The
random intercept, ξijk, represents the ith individual’s
deviation from the population mean intercept and mod-
els the correlation in the repeated measures within sub-
ject. εijk is the residual error term. We estimated the
effect of PM mass and PM metal component on post-
exposure DNA sample with the following model: Yij =
b0 + b1(Exposure)i + b2(CpG position)j + ξij + εij where
b0 is the overall intercept; b1 is the regression coefficient
representing the exposure effect; b2 is the regression
coefficient for the difference between CpG dinucleotides
position; i = 1,2,...,63 represents the subject; j = 1,2...4/7
represents the CpG dinucleotides position. The random
intercept, ξij, represents the ith individual’s deviation
from the population mean intercept and models the cor-
relation in the repeated measures within subject. εij is
the residual error term.
Covariates for multivariate models included the fol-
lowing potential confounders: age, body mass index
(BMI), smoking and percent granulocytes in the differ-
ential blood count. We further conducted analyses with-
out adjusting for percent granulocytes and did not
observe meaningful differences in the results from the
adjusted models. The independent variables used in
multivariable models were selected a priori and included
general characteristics potentially associated with cancer
risk or other carcinogenic exposures. An unstructured
covariance structure was used to model the within-sub-
ject errors. In order to compare the magnitude of the
associations of DNA methylation genes with different
exposures, we calculated standardized regression coeffi-
cients which express the effects on DNA methylation
genes as the fraction of a standard deviation of DNA
methylation genes associated with a standard deviation
increase in exposure. The Kenword-Roger approxima-
tion was used to estimate denominator degrees of free-
dom. A p-value < 0.05 was considered statistically
significant. All statistical analyses were performed in
SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Characteristics and exposure levels of the study subjects
Characteristics and exposure levels of the study subjects
were reported previously [21]. Briefly, the mean age of
the study subjects was 44 years (range between 27 and
55 years). Twenty-five subjects (40%) were current smo-
kers, who reported a mean number of 13.0 (SD = 7.2)
cigarettes smoked every day. The mean BMI of the
study participants was 26.5 Kg/m2 (SD = 2.7). Table 1
shows the mean estimated levels of inhalable PM mass
and air metal concentrations. For both PM mass and
metal levels, the study subjects showed wide ranges of
exposure levels. For instance, the minimum and maxi-
mum PM10 levels were 73.72 μg/m
3 and 1220.17 μg/m3,
respectively. For some of the exposures (i.e., aluminum,
manganese, zinc, and lead), the maximum individual
exposure was more than 200 times higher than the
minimum individual exposure.
The matrix of correlations between exposure levels
(Additional file 1, Table S2) showed that nickel was
positively correlated with all other metals and PM levels
(r between 0.22 and 0.84). Zinc also showed positive
correlations (r between 0.25 and 0.48) with nickel,
arsenic, lead, iron as well as with PM10 and PM1.
Arsenic showed positive correlations (r between 0.25
and 0.84) with manganese, nickel, zinc, lead, and iron.
Lead was correlated (r between 0.28 and 0.99) with all
other metals. Iron showed positive correlations (r
between 0.26 and 0.77) with all other metals, except alu-
minum, as well as with PM10 and PM1 levels. PM10 and
PM1 were positively correlated (r = 0.91).
Table 1 Distribution of PM mass and metals contained in
PM* among study subjects (N = 63)
Exposure
(μg/m3)
N Mean (SD) Min Percentile Max
25th 50th 75th
PM10 63 233.42 (214.56) 73.72 152.23 179.45 222.86 1220.17
PM1 63 8.48 (6.18) 1.71 3.51 9.01 11.35 30.49
Aluminum 63 8.50 (18.07) 0.40 1.48 2.05 7.41 84.07
Manganese 63 11.26 (30.41) 0.11 1.20 4.63 10.77 174.79
Nickel 63 0.30 (0.18) 0.02 0.23 0.25 0.46 0.72
Zinc 63 18.85 (26.37) 0.26 1.47 8.45 32.28 129.06
Arsenic 63 0.10 (0.1) 0.01 0.02 0.07 0.17 0.31
Lead 63 7.53 (17.46) 0.13 0.63 2.87 9.52 99.90
Iron 63 32.02 (22.08) 0.96 18.00 25.64 48.69 88.43
*Metals were measured in the PM10 fraction of PM mass
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Changes in DNA methylation during the work week
We compared DNA methylation in the baseline sam-
ples with those in the post-exposure samples (Table 2).
Individuals trajectories for all subjects are shown in
Figure 1. APC methylation showed non-significant
increases at all four CpG sites evaluated. When the
four CpG sites were combined, the mean APC methy-
lation level significantly increased from baseline 4.65%
5 mC to post-exposure 4.89% 5 mC (p-value = 0.005).
DNA methylation levels at the seven individual p16
promoter CpG sites showed inconsistent patterns. Of
the seven CpG sites, methylation increased significantly
only at CpG site 1 in post-exposure samples (from
baseline 2.02% 5 mC to 2.34% 5 mC, p-value = 0.012).
The remaining six CpG sites showed non-significant or
no increase in post-exposure samples. The mean
methylation level of the combined seven CpG sites
showed a significant increase from 2.20% 5 mC at
baseline to 2.34% 5 mC after 4 work days (post-expo-
sure) (p-value = 0.006). By contrast, p53 methylation
decreased significantly at CpG site 4 (from 6.96% 5
mC to 6.59% 5 mC, p-value = 0.006), but not in the
other three CpG sites. The mean methylation of the
combined four p53 sites showed a significant decrease
from 6.36% 5 mC in baseline samples to 6.16% 5 mC
in post-exposure samples (p-value = 0.015). RASSF1A
methylation showed significant decreases at all four
CpG sites evaluated. The mean methylation value of
the combined four RASSF1A CpG sites decreased
significantly from 8.17% 5 mC in baseline samples to
7.08% 5 mC in post-exposure samples (p-value
< 0.001).
Associations of DNA methylation with exposure to PM
mass and metal component
The correlations of PM mass and its metal compo-
nents with post-exposure promoter DNA methylation
were examined. This set of analyses takes advantage of
the large differences in exposure levels among the
study subjects. We present results from unadjusted
models as well as from models adjusted for age, BMI,
smoking, proportion of granulocytes in the differential
blood count. For each gene, the mean methylation
levels of all CpG sites (Table 3) and the methylation
levels of each individual CpG site (Additional file 1,
Table S3, S4, S5, and S6) were regressed over the
exposure levels. The mean methylation level of four
CpG sites in APC promoter region was positively asso-
ciated with the levels of PM10 (bstd = 0.27, 95% CI:
0.14-0.40), PM1 (bstd = 0.23, 95% CI: 0.10-0.37) and
aluminum (bstd = 0.15, 95% CI: 0.00-0.29) in the unad-
justed regression. The adjusted regression confirmed
significant associations of APC methylation with PM10
(bstd = 0.27, 95% CI: 0.13-0.40), and PM1 (bstd = 0.23,
95% CI: 0.09-0.38), and a borderline significant associa-
tion with aluminum (bstd = 0.14, 95% CI: 0.00-0.29).
The mean methylation level of seven CpG sites in p16
promoter region was positively associated with the
levels of zinc in both the unadjusted (bstd = 0.18, 95%
CI 0.00-0.35) and adjusted (bstd = 0.19, 95% CI: 0.02-
0.37) regressions. RASSF1A promoter methylation level
measured in four CpG sites was negatively associated
with the level of zinc exposure in both the unadjusted
(bstd = -0.18, 95% CI: -0.35–0.01) and adjusted regres-
sions (bstd = -0.21, 95% CI: -0.37–0.05). p53 methyla-
tion did not show any significant associations with the
exposures evaluated.
Table 2 Promoter CpG site DNA methylation of four
tumor suppressor genes measured in post-exposure and
baseline samples
CpG site N DNA methylation
Baseline sample Post-exposure
sample
p-
value
APC (%5 mC)
site 1 60 5.77 (5.41; 6.13) 6.13 (5.77; 6.49) 0.06
site 2 60 5.39 (5.10; 5.68) 5.45 (5.16; 5.74) 0.72
site 3 60 3.63 (3.32; 3.93) 3.92 (3.62; 4.23) 0.11
site 4 60 3.86 (3.56; 4.15) 4.06 (3.77; 4.35) 0.25
All sites
combined
60 4.65 (3.70; 5.61) 4.89 (3.94; 5.85) 0.005
p16 (%5 mC)
site 1 61 2.02 (1.81; 2.22) 2.34 (2.13; 2.55) 0.012
site 2 61 2.75 (2.51; 2.98) 2.9 (2.66; 3.14) 0.20
site 3 61 1.66 (1.43; 1.89) 1.88 (1.65; 2.11) 0.11
site 4 61 2.21 (2.05; 2.36) 2.17 (2.01; 2.33) 0.70
Site5 61 1.84 (1.57; 2.12) 1.93 (1.65; 2.20) 0.60
Site 6 61 1.71 (1.49; 1.92) 1.78 (1.56; 2.00) 0.58
Site 7 61 3.11 (2.83; 3.40) 3.31 (3.03; 3.60) 0.15
All sites
combined
61 2.2 (1.78; 2.62) 2.34 (1.92; 2.76) 0.006
p53 (%5 mC)
site 1 58 3.02 (2.83; 3.22) 2.93 (2.73; 3.13) 0.16
site 2 58 11.88 (11.26;
12.50)
11.56 (10.94;
12.18)
0.13
site 3 58 3.57 (3.37; 3.78) 3.56 (3.35; 3.76) 0.85
site 4 58 6.96 (6.52; 7.41) 6.59 (6.14; 7.03) 0.006
All sites
combined
58 6.36 (2.93; 9.79) 6.16 (2.73; 9.60) 0.015
RASSF1A (%5 mC)
site 1 57 3.68 (3.23; 4.13) 3.14 (2.69; 3.59) 0.003
site 2 57 10.14 (9.01;
11.27)
8.59 (7.45; 9.72) <
0.001
site 3 57 8.43 (7.16; 9.70) 7.21 (5.94; 8.49) 0.009
site 4 57 10.61 (9.34;
11.88)
9.22 (7.95;
10.49)
0.002
All sites
combined
57 8.17 (5.44;
10.90)
7.08 (4.36; 9.81) <
0.001
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Figure 1 DNA methylation levels measured in baseline and post-exposure samples. The spaghetti plots show the changes of individuals’
DNA methylation levels in APC (A), P16 (B), P53 (C), RASSF1A (D) (black lines) and the mean change (bolded red lines) between baseline and
post-exposure samples.
Table 3 Association of PM mass and metal components with methylation of four tumor suppressor genes measured in
post-exposure samples (N = 63)
Exposures APC p16 p53 RASSF1A
bstd 95% CI bstd 95% CI bstd 95% CI bstd 95% CI
Unadjusted regression
PM10 0.27
a 0.14 to 0.40 0.02 -0.17 to 0.20 0.00 -0.12 to 0.11 0.01 -0.16 to 0.18
PM1 0.23
b 0.10 to 0.37 0.02 -0.16 to 0.20 -0.06 -0.17 to 0.04 -0.01 -0.18 to 0.16
Aluminium 0.15c 0.00 to 0.29 0.00 -0.18 to 0.18 0.04 -0.07 to 0.15 0.01 -0.15 to 0.18
Manganese 0.11 -0.03 to 0.26 -0.03 -0.22 to 0.15 -0.02 -0.15 to 0.11 0.11 -0.05 to 0.28
Nickel 0.08 -0.07 to 0.23 0.00 -0.18 to 0.18 0.04 -0.06 to 0.14 -0.02 -0.19 to 0.15
Zinc 0.06 -0.08 to 0.21 0.18c 0.00 to 0.35 -0.06 -0.15 to 0.03 -0.18c -0.35 to -0.01
Arsenic 0.01 -0.15 to 0.17 -0.02 -0.20 to 0.16 0.05 -0.05 to 0.15 0.01 -0.17 to 0.18
Lead 0.12 -0.03 to 0.26 -0.01 -0.19 to 0.17 -0.04 -0.17 to 0.09 0.08 -0.09 to 0.25
Iron 0.05 -0.10 to 0.20 -0.02 -0.20 to 0.16 -0.03 -0.12 to 0.07 -0.06 -0.24 to 0.12
Multivariable regression*
PM10 0.27
a 0.13 to 0.40 0.01 -0.17 to 0.20 0.00 -0.12 to 0.12 0.03 -0.13 to 0.19
PM1 0.23
b 0.09 to 0.38 0.02 -0.17 to 0.21 -0.06 -0.16 to 0.05 0.04 -0.14 to 0.21
Aluminium 0.14 0.00 to 0.29 0.00 -0.19 to 0.18 0.05 -0.06 to 0.17 0.05 -0.11 to 0.21
Manganese 0.12 -0.03 to 0.26 -0.03 -0.22 to 0.15 -0.02 -0.15 to 0.12 0.12 -0.04 to 0.28
Nickel 0.08 -0.08 to 0.23 0.00 -0.18 to 0.19 0.04 -0.06 to 0.13 -0.03 -0.19 to 0.13
Zinc 0.08 -0.07 to 0.23 0.19c 0.02 to 0.37 -0.07 -0.16 to 0.03 -0.21c -0.37 to -0.05
Arsenic 0.02 -0.14 to 0.18 -0.01 -0.20 to 0.18 0.04 -0.07 to 0.14 -0.04 -0.21 to 0.13
Lead 0.12 -0.02 to 0.27 -0.01 -0.19 to 0.18 -0.05 -0.18 to 0.09 0.08 -0.08 to 0.24
Iron 0.05 -0.10 to 0.21 -0.01 -0.20 to 0.17 -0.04 -0.13 to 0.06 -0.08 -0.25 to 0.09
* multivariable mixed effects models adjusted for age, BMI, smoking, % of granulocytes
a p ≤ 0.0001; b p ≤ 0.001; c p ≤ 0.05
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Correlation with other biomarkers previously examined in
the study
In addition, we have previously examined a number of
biomarkers in this study population, including mito-
chondria DNA copy number variation, global methyla-
tion levels measured in two repetitive elements, Alu and
LINE-1, and hTERT, a telomere length maintenance
gene [10,22,23]. We did not observe significant correla-
tions between these markers with DNA methylation
level in 4 tumor suppressor genes (Additional file 1,
Table S7).
Discussion
In the present study, we showed that the mean methyla-
tion levels of promoter CpG sites were significantly
associated with the exposure to PM and certain metal
components. In particular, the mean DNA methylation
levels of the CpG sites measured in APC or p16 promo-
ter increased significantly in post-exposure DNA sam-
ples. By contrast, the mean of p53 or RASSF1A
promoter CpG sites methylation decreased in post-expo-
sure DNA samples. CpG site-specific analyses did not
show consistent patterns of DNA methylation changes
in any of the four genes.
Evidence in human subjects is rapidly mounting to
establish associations of DNA methylation alterations
with environmental exposures. Such methylation
changes can persist over time even in the absence of the
conditions that established them and even accumulate
in response to continuous exposure [24-26]. Exposure to
air pollution, particularly to ambient PM, has been asso-
ciated with increased lung cancer risk [1,2]. Aberrant
DNA promoter methylation of tumor suppresser genes,
including hypermethylation of p16 [27,28], APC [29]
and RASSF1A [28,30], and hypomethylation of p53 [31],
has been observed in blood leukocyte DNA from lung
cancer patients, suggesting that PBL DNA methylation
may serve as a cancer-related biomarker.
The four genes of interest in our study are involved in
cell-cycle control (p16), invasion and metastasis (APC),
apoptosis (p53) and Ras signaling (RASSF1A) and have
been shown to be altered in lung cancer patients’ blood
DNA [27-31]. Some of our findings are in line with pre-
vious reports. Zhang et al and Chanda et al found
hypermethylation of p16 tumor suppressor gene in
blood DNA from individuals exposed to emissions from
indoor unventilated-stove coal usage [9] and individuals
exposed to high-level arsenic [8]. Expression of p16, one
of the most promising early epigenetic markers for the
detection of lung cancer [32], was demonstrated to be
regulated by promoter methylation [33]. Hypermethyla-
tion of p16 has been detected in blood leukocyte DNA
from cancer-free smokers [34], lung cancer smokers
[27,28] and in lung tissue from diesel exhaust-exposed
rats [35]. APC promoter hypermethylation, another
early event of tumorigenesis, has been extensively stu-
died in lung tumors [36]. APC promoter hypermethyla-
tion has also been seen in lung tissue in healthy subjects
exposed to cigarette smoke [37] and blood in lung can-
cer patients [29]. Our finding, for the first time, shows
that air pollution may induce blood leukocyte APC pro-
moter hypermethylation. p53 is a key factor in DNA
damage-signaling pathway, and p53 hypomethylation is
associated with DNA double strand breaks and chromo-
somal instability [31]. In a previous human study, we
observed p53 hypomethylation in blood DNA in Polish
male non-smoking coke-oven workers exposed to poly-
cyclic aromatic hydrocarbons (PAHs) [38,39], which is
similar to findings in smoker lung cancer patients [31].
Our finding further suggests that p53 blood leukocyte
hypomethylation may also occur in healthy subjects who
are exposed to PM. Although hypermethylated
RASSF1A promoter is frequently observed in the blood
DNA of lung cancer patients [28,30], we found an
inverse association between mean promoter RASS1FA
methylation and PM exposure. It is possible that our
results might represent tissue-specific effects of PM
exposures on blood leukocytes, as well as a false positive
finding due to the limited sample size. Different tumor
suppressor genes may behave differently with respect to
carcinogens. Air pollution may cause hypo- or hyper-
methylation in each individual gene depending on the
role of the gene in cancer development. In our study,
we observed positive association of p16 methylation
with zinc, and negative association of RASSF1A methy-
lation with zinc in both unadjusted and adjusted regres-
sions. Zinc is a major component in PM in steel-
production plants, and was present at high levels in PM
measured in the present study (Table 1). Zinc inhalation
has been shown to induce inflammation and oxidative
stress in animal studies [40,41]. Kodavanti et al have
also demonstrated that leachable zinc from PM induced
both pulmonary and systemic changes in multiple in
vivo toxicology experiments [42]. Furthermore, a study
has shown that inhalation of soluble zinc sulfate, even at
low levels (10 μg/m3), caused gene expression change in
heart tissue in healthy rats [43].
PM and its metal components may affect DNA methy-
lation through several cellular processes, including oxi-
dative stress/reactive oxygen species (ROS) generation
and systemic inflammation/immune deficiency [44,45],
the two major components in the etiology of cancer
[46]. These cellular processes have been shown to be
induced by exposure to PM [47,48] and associated with
altered DNA methylation patterns [49].
Our study was based on occupationally PM-exposed
volunteers who worked in several work areas of the
same factory and did not include a different population
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of subjects without a specific condition of exposure to
PM. Limiting our investigation to individuals who have
all been working in the same work facility avoided
potential concerns related to the selection of external
referents who might have differed from the exposed
population in terms of socioeconomic factors and other
characteristics determining hiring into the plant [50].
The differences in the individual levels of exposure in
our study group were large, which provided sufficient
contrast for identifying exposure-related changes in
DNA methylation. For example, the lowest level of
PM10 observed in our study population (73.72 μg/m
3)
was only marginally higher than ambient PM10 levels
measured in the geographic area where the plant is
located [average annual ambient PM10 levels between 41
and 57 μg/m3 were recorded in the year of the study by
different ambient monitoring stations in Brescia area]
[51], whereas the highest level was 1220.17 μg/m3. It is
worth noting that, although our study was based on a
group of foundry workers with higher average exposures
than the general population, the levels of exposure to
metals in our study were all lower than the commonly
accepted threshold limits for industrial settings [52]. As
foundry workers may have additional exposures [53-57],
we cannot exclude that exposures other than PM might
have contributed to the observed effects, although study
subjects in our study were in a modern facility with
state-of-the-art systems for exposure reduction. A lim-
itation of the study is that it did not include an unex-
posed comparison group. We cannot exclude that
effects of potential changes in life-style from the start to
the end of the week might have played a role in generat-
ing the observed associations. However, this group of
foundry workers showed wide differences in exposures
between individuals. The dose-response associations that
we found between PM and APC methylation, and
between zinc and p16 and RASSF1A methylation all
hint to specific exposure-related effects.
In summary, we observed hypermethylation of p16
and APC, and hypomethylation of RASSF1A and p53 in
a group of healthy foundry workers who had higher
levels of exposure to PM compared to the general popu-
lations. Altered DNA methylation of tumor suppressor
genes in easily obtainable cells such as PBLs may have
potentials for developing biomarkers to detect biological
alterations in PM-exposed subjects. These results sug-
gest that such methylation alterations may reflect pro-
cesses related to PM-induced lung carcinogenesis.
However, because our study did not include lung cancer
or other carcinogenesis-related endpoints, we cannot
make inference on the biological significance of our
findings. Further studies in larger populations are
required before any firm conclusion could be reached
on whether PM exposed individuals with such DNA
methylation alterations are at higher risk for lung
cancer.
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